All-trans retinoic acid negatively regulates cytotoxic activities of nature killer cell line 92

Biochemical and Biophysical Research Communications

Volumn 352, Issue 1, 2007, Pages 42-47

  Li, Ang ^a   He, Meilan ^a   Wang, Hui ^a   Qiao, Bin ^b   Chen, Ping ^a   Gu, Hua ^a   Zhang, Mengjie ^a   He, Shengxiang ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

ATRA; Nature killer receptors; NF B; NK92 cells

Indexed keywords

GAMMA INTERFERON; GRANZYME B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CELL LINE; CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION; GRANZYMES; HUMANS; I-KAPPA B KINASE; INTERFERON TYPE II; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 33751423135     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.132     Document Type: Article

References (31)

1. Blomhoff H.K., and Smeland E.B. Role of retinoids in normal hematopoiesis and in the immune system. In: Blomhoff R. (Ed). Vitamin A in Health and Disease (1998), Marcel Dekker, New York 451
2. Semba R.D. The role of vitamin A and related retinoids in immune function. Nutr. Rev. 56 (1998) 38-48
3. Ross A.C. Vitamin A status: relationship to immunity and antibody response. Proc. Soc. Exp. Biol. Med. 200 (1992) 303-320
4. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 267 (2000) 4315-4324
5. Bastien J., and Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328 (2004) 1-16
6. Engedal N., Ertesvag A., and Blomhoff H.K. Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. Int. Immuno. 16 (2004) 443-453
7. Rasooly R., Schuster G.U., Gregg J.P., Xiao J., Chandraratna R.A.S., and Stephensen C.B. Retinoid X receptor agonists increase Bcl2a1 expression and decrease apoptosis of naive T lymphocytes. J. Immunol. 175 (2005) 7916-7929
8. Chen Q., and Ross A.C. Vitamin A and immune function: Retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc. Natl. Acad. Sci. USA 102 (2005) 14142-14149
9. Kusmartsev S., Cheng F., Yu B., Nefedova Y., Sotomayor E., Lush R., and Gabrilovich D. all-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 63 (2003) 4441-4449
10. Devaux C.S., Devaux Y., Cannard V.L., Grosjean S., Egly C.R., Zannad F., Meistelman C., Mertes P., and Longrois D. Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RAR-a agonist in vivo. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E525-E535
11. Jason J., Archibald L.K., Nwanyanwu O.C., Sowell A.L., Buchanan I., Larned J., Bell M., Kazembe P.N., Dobbie H., and Jarvis W.R. Vitamin A levels and immunity in humans. Clin. Diagn. Lab. Immun. 9 (2002) 616-621
12. Dawson H.D., Li N., DeCicco K.L., Nibert J.A., and Ross A.C. chronic marginal vitamin A status reduces natural killer cell number and function in aging lewis rats. J. Nutr. 129 (1999) 1510-1517
13. Gong J.H., Maki G., and Klingemann H.G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8 (1994) 652-658
14. Nagashima S., Mailliard R., Kashii Y., Reichert T.E., Herberman R.B., Robbins P., and Whiteside T.L. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood 91 (1998) 3850-3861
15. Szabova L., Macejova D., Dvorcakova M., Mostbock S., Blazickova S., Zorad S., Walrand S., Cardinault N., Vasson M.-P., Rock E., and Brtko J. Expression of nuclear retinoic acid receptor in peripheral blood mononuclear cells (PBMC) of healthy subjects. Life Sci. 72 (2003) 831-836
16. Mavoungou E., Bouyou-Akotet M.K., and Kremsner P.G. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30). Clin. Exp. Immunol. 139 (2004) 287-296
17. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., Lanier L.L., Groh V., Spies T., Ebert E.C., Green P.H., and Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
18. Faggioni R., Feingold K.R., and Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 15 (2001) 2565-2571
19. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin. Immunol. 118 (2006) 1-10
20. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., and Young H.A. Interaction of NF-κB and NFAT with the interferon-γ promoter. J. Biol. Chem. 272 (1997) 30412-30420
21. Huang C., Bi E., Hu Y., Deng W., Tian Z., Dong C., Hu Y., and Sun B. A novel NF-κB binding site controls human granzyme B gene transcription. J. Immunol. 176 (2006) 4173-4181
22. Frankenburg S., Wang X., and Milner Y.. Vitamin A inhibits cytokines produced by type 1 lymphocytes in vitro. Cell. Immunol. 185 (1998) 75-81
23. Yu S., Xia M., Xu W., Chu Y., Wang Y., and Xiong S. All-trans retinoic acid biases immune response induced by DNA vaccine in a Th2 direction. Vaccine 23 (2005) 5160-5167
24. Austenaa L.M.I., Carlsen H., Ertesvag A., Alexander G., Blomhoff H.K., and Blomhoff R. Vitamin A status significantly alters nuclear factor-κB activity assessed by in vivo imaging. FASEB J. 18 (2004) 1255-1257
25. Zhou J., Zhang J., Lichtenheld M.G., and Meadows G.G. A role for NF-κB activation in perforin expression of NK cells upon IL-2 receptor signaling. J. Immunol. 169 (2002) 1319-1325
26. Perez-Lorenzo R.., Nunez-Oreza L.A., Garma-Quen P.M., Lopez-Pacheco E.., and Bricaire-Bricaire G.. Peripheral blood mononuclear cells proliferation and Th1/Th2 cytokine production in response to streptococcal M protein in psoriatic patients. Int. J. Dermatol. 45 (2006) 547-553
27. Cameron A.L., Kirby B., and Griffiths C.E. Circulating natural killer cells in psoriasis. Br. J. Dermatol. 149 (2003) 160-164
28. Ottaviani C., Nasorri F., Bedini C., de Pita O., Girolomoni G., and Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur. J. Immunol. 36 (2006) 118-128
29. Cameron A.L., Kirby B., Fei W., and Griffiths C.E. Natural killer and natural killer-T cells in psoriasis. Arch. Dermatol. Res. 294 (2002) 363-369
30. Gilhar A.., Ullmann Y., Kerner H., Assy B., Shalaginov R., Serafimovich S.., and Kalish R.S. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J. Invest. Dermatol. 119 (2002) 384-391
31. Piedrafita F.J., and Phahl M. Nuclear retinoid receptors and mechanisms of action. In: Nau H., and Blaner W.S. (Eds). Handbook of Experimental Pharmacology: Retinoids (1999), Spring-Verlag, New York 153-184